A problem-oriented approach to safety issues in drug development and beyond.

Area of Science:

• Pharmacovigilance
• Drug Safety
• Risk Management

Background:

• Pharmaceutical product safety requires integrating information from diverse sources throughout its lifecycle.
• Current regulatory trends emphasize early risk identification and management for pharmaceutical products.

Purpose of the Study:

• To introduce the Safety Evaluation Plan (SEP) as a tool for problem-oriented safety analysis.
• To support early identification and evidence-based evaluation of pharmaceutical safety issues.

Main Methods:

• Implementing a problem-oriented analysis integrating information from all relevant sources.
• Utilizing a status summary updated regularly with new study and clinical trial data.
• Incorporating postmarketing data for continuous safety assessment.

Main Results:

• The SEP facilitates a proactive approach to safety problem management, enabling prompt risk assessment and reduction.
• A problem-oriented approach supports regulatory expectations for risk assessment and management.
• The SEP provides a unified global assessment for each identified safety issue.

Conclusions:

• The problem-oriented approach, supported by the SEP, enhances communication and credibility in managing pharmaceutical safety.
• Adapting internal structures is necessary to fully support this interdisciplinary safety evaluation process.
• This approach leads to realistic expectations and sustained credibility in addressing safety concerns.